| 1 | 999818 | Effects of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleoside transport in HeLa cells. | Biochemistry | 1976 Dec 14 |
1 |
| 2 | 1280674 | Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients. | J Clin Oncol | 1992 Dec |
2 |
| 3 | 1306884 | Use of GM-CSF in children after high-dose chemotherapy. | Med Pediatr Oncol Suppl | 1992 |
1 |
| 4 | 1310581 | Irreversible inhibition of human cytomegalovirus replication by topoisomerase II inhibitor, etoposide: a new strategy for the treatment of human cytomegalovirus infection. | Antiviral Res | 1992 Jan |
2 |
| 5 | 1315778 | Participation of poly(ADP-ribose) polymerase in the drug sensitivity in human lung cancer cell lines. | J Cancer Res Clin Oncol | 1992 |
1 |
| 6 | 1318951 | Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study. | J Clin Oncol | 1992 Jul |
1 |
| 7 | 1323814 | Platinum/oral etoposide therapy in non-small cell lung cancer. | Oncology | 1992 |
1 |
| 8 | 1330082 | Multidrug resistance in a small cell lung cancer line: rapid selection with etoposide and differential chemosensitization with cyclosporin A. | Anticancer Drugs | 1992 Aug |
1 |
| 9 | 1334113 | Pharmacologic validation of human tumor clonogenic assays based on pleiotropic drug resistance: implications for individualized chemotherapy and new drug screening programs. | Int J Cell Cloning | 1992 Nov |
1 |
| 10 | 1336489 | Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation. | Jpn J Cancer Res | 1992 Nov |
1 |
| 11 | 1336899 | Oral etoposide in small cell lung cancer. | Semin Oncol | 1992 Dec |
3 |
| 12 | 1346631 | Development of multidrug resistance in a primitive neuroectodermal tumor cell line. | J Neurosurg | 1992 Mar |
1 |
| 13 | 1353119 | Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM. | J Urol | 1992 Aug |
1 |
| 14 | 1353251 | Expression of c-fos in human and murine multidrug-resistant cells. | Mol Pharmacol | 1992 Jul |
1 |
| 15 | 1354408 | Establishment and characterization of an etoposide-resistant human small cell lung cancer cell line. | Acta Med Okayama | 1992 Jun |
1 |
| 16 | 1358264 | Taxol: a review of its preclinical in vivo antitumor activity. | Anticancer Drugs | 1992 Aug |
1 |
| 17 | 1370437 | The relationship between multi-drug resistance and resistance to natural-killer-cell and lymphokine-activated killer-cell lysis in human leukemic cell lines. | Int J Cancer | 1992 Jan 21 |
2 |
| 18 | 1377186 | Potentiation by novobiocin of the cytotoxic activity of etoposide (VP-16) and teniposide (VM-26). | Int J Cancer | 1992 Jul 9 |
1 |
| 19 | 1382255 | Combined chemotherapy and radiotherapy versus best supportive care in the treatment of inoperable non-small-cell lung cancer. | Oncology | 1992 |
1 |
| 20 | 1384135 | Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen. | Semin Oncol | 1992 Feb |
1 |
| 21 | 1402650 | Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. | J Exp Med | 1992 Oct 1 |
1 |
| 22 | 1403039 | Etoposide and carboplatin in neuroblastoma: a French Society of Pediatric Oncology phase II study. | J Clin Oncol | 1992 Oct |
1 |
| 23 | 1403040 | Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance. | J Clin Oncol | 1992 Oct |
6 |
| 24 | 1403041 | Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. | J Clin Oncol | 1992 Oct |
7 |
| 25 | 1411635 | Clinical pharmacology and schedule dependency of the podophyllotoxin derivatives. | Semin Oncol | 1992 Apr |
2 |
| 26 | 1421436 | Expression of resistance to etoposide and vincristine in vitro and in vivo after X-irradiation of ovarian tumor cells. | Anticancer Drugs | 1992 Aug |
1 |
| 27 | 1432038 | Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma. | J Neurooncol | 1992 Oct |
1 |
| 28 | 1492228 | High-dose etoposide (VP-16)-containing preparatory regimens in allogeneic and autologous bone marrow transplantation for hematologic malignancies. | Semin Oncol | 1992 Dec |
1 |
| 29 | 1514527 | Etoposide plus carboplatin admixture. Phase I study of five- or seven-day continuous infusion. | Am J Clin Oncol | 1992 Aug |
1 |
| 30 | 1515645 | Sensitivity of fresh acute myeloid leukemia cells to etoposide: relationship with cell growth characteristics and DNA single-strand breaks. | Blood | 1992 Sep 1 |
1 |
| 31 | 1515884 | Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. | Bone Marrow Transplant | 1992 Jul |
1 |
| 32 | 1517797 | Pharmacology of intrathecal VP-16-213 in dogs. | J Neurooncol | 1992 Jul |
1 |
| 33 | 1525405 | Activity of etoposide (VP-16) and teniposide (VM-26) in exponential and plateau phase human tumor cell cultures. | Anticancer Drugs | 1992 Jun |
1 |
| 34 | 1534319 | Pharmacologic interactions between the resistance-modifying cyclosporine SDZ PSC 833 and etoposide (VP 16-213) enhance in vivo cytostatic activity and toxicity. | Int J Cancer | 1992 May 28 |
2 |
| 35 | 1537631 | Pre-treatment of a human T-lymphoblastoid cell line with L-asparaginase reduces etoposide-induced DNA strand breakage and cytotoxicity. | Int J Cancer | 1992 Feb 20 |
6 |
| 36 | 1550597 | The human multidrug resistance 1 promoter has an element that responds to serum starvation. | Biochem Biophys Res Commun | 1992 Mar 16 |
1 |
| 37 | 1551112 | Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide. | Cancer Res | 1992 Apr 1 |
6 |
| 38 | 1578365 | Human cytochrome P450 metabolism of teniposide and etoposide. | J Pharmacol Exp Ther | 1992 May |
1 |
| 39 | 1581902 | Relationship of VP-16 to the classical multidrug resistance phenotype. | Cancer Res | 1992 May 15 |
1 |
| 40 | 1611612 | Treatment of early recurrent medulloblastoma in children with cisplatin and etoposide: a preliminary report. | Childs Nerv Syst | 1992 May |
1 |
| 41 | 1645864 | Lack of interference of DNA single-strand breaks with the measurement of double-strand breaks in mammalian cells using the neutral filter elution assay. | Nucleic Acids Res | 1991 May 25 |
1 |
| 42 | 1646050 | High dose carboplatin/VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors. | Bone Marrow Transplant | 1991 Jan |
1 |
| 43 | 1648924 | Cell death induced by topoisomerase inhibitors. Role of calcium in mammalian cells. | Biochem Pharmacol | 1991 Jun 21 |
1 |
| 44 | 1650363 | Effects of quinolone derivatives on eukaryotic topoisomerase II. A novel mechanism for enhancement of enzyme-mediated DNA cleavage. | J Biol Chem | 1991 Aug 5 |
2 |
| 45 | 1651994 | Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study. | J Clin Oncol | 1991 Sep |
1 |
| 46 | 1651995 | Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer. | J Clin Oncol | 1991 Sep |
1 |
| 47 | 1654205 | Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors. | Cancer Res | 1991 Sep 15 |
1 |
| 48 | 1655218 | 5-Fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer. | Cancer | 1991 Sep 1 |
1 |
| 49 | 1657205 | Management of esophageal, gastric, pancreatic, and hepatobiliary neoplasms. | Curr Opin Oncol | 1991 Aug |
1 |
| 50 | 1657846 | Characterization of an etoposide-resistant human K562 cell line, K/eto. | Jpn J Cancer Res | 1991 Sep |
1 |